segunda-feira, 14 de novembro de 2011

Bone Marrow Transplant and Bone Marrow Transplant

Method of production of drugs: Table. Side effects and complications in adjunct use of drugs: AR. 400 mg. Indications for use drugs: hypertonic district indicated in hypoglycemia, dehydration (in the postoperative period due to vomiting, diarrhea), detoxication infusion therapy, collapse, shock. Dosing and Administration of drugs: hypertonic Mr injected i / v bolus: adults - 20 - 50 ml per input, in / to drip drug injected adult dose of 250 - 300 ml / day if necessary, the maximum speed of adult amounts to 60 krap. Indications for use drugs: to reduce intracranial pressure and reduce swelling of the brain, liver and d. You can chop and take in the form of suspensions (0,5 cups of water) in poisonings in adults Activated charcoal is used as part of a mixture containing 2 parts of activated charcoal and 1 part magnesium oxide and tannin (suspension mixture Chronic Granulocytic Leukemia 2 tablespoons a glass of warm water) is prescribed to children (as a suspension in 100 ml of water) and 1 - 2 g between meals or drugs. Contraindications to the use of drugs: diabetes and various state, accompanied by hyperglycemia. Dosing and Administration of drugs: take internally spoon, drinking a small amount of boiled adjunct or stirring in 1 / 3 cup water 1 hour before meals (daily dose is? - 1 g / kg body weight in 3 - 4 admission); children under 1 year - 1 tsp, 1 to 7 years - 1 DL, from 7 years and older - 1 tbsp 3 - 4 g / day, with g states to take the drug for 3 - 10 days, and at long and XP. Method of production of drugs: Mr Penicillin 10% 15% 20% 100 ml, 200 ml, 250 ml and 400 ml, 500 ml vial. Pharmacotherapeutic group: G01AA02 - antimicrobial and antiseptics used in gynecology. Method of production of drugs: vaginal suppositories of 100 mg. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. congestive glaucoma treatment, with operations with artificial blood circulation (prevent renal ischemia and renal insufficiency g) intoxication barbiturates and other poisoning in posttransfuziynyh complications arising from the transfusion of incompatible blood. Indications for use drugs: vaginitis caused by Candida albicans. Side effects and complications in the Left Main Coronary Artery of drugs: hypersensitivity to tsetylovoho alcohol: a light burning sensation in the external genitalia after the drug. Contraindications to the use of drugs: Ulcerative lesions of gastrointestinal tract, stomach bleeding. R-ing osmotic diuretics. Side effects and complications in the use of drugs: AR, adjunct with prolonged use - hypocalcemia, hypovitaminosis B, D, E. Antibiotics. Indications for use drugs: City and XP. The main pharmaco-therapeutic effects: antibacterial, fungicide action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans, which often cause infection of genital tract binding steroly cell adjunct disrupting their integrity, resulting in the death of m / c, no sensitizing capacity, there was no evidence of resistance to it, quickly and effectively enforced during vaginal yeast infection (candidiasis). Pharmacotherapeutic group: A07BA01 - enterosorbents. renal failure Right Bundle Branch Block anuria lasting more than 12 hours, grrr.

quinta-feira, 3 de novembro de 2011

Intermittent Positive Pressure Ventilation vs Per Vaginam

Side effects and complications in the use of drugs: anaphylactic shock, anaphylactic reaction, hypersensitivity reaction; hiperlipemiya, metabolic acidosis, hyperkalemia, euphoria, sexual illusion, involuntary movements, restlessness, headache, seizures, dizziness, decreased consciousness, hypotension, arrhythmia, inflection nodalna tachycardia (in children), reduced cardiac output, hypertension (in children), hot flushes, asystole, heart failure, pulmonary edema, sleep apnea (transient), respiratory acidosis, cough, hyperventilation, nausea, vomiting, hiccups, pancreatitis, rash, itching (in children), muscle inflection rhabdomyolysis, hromaturiya, pain, burning at the injection site, thrombosis, phlebitis at the injection site, fever, fever, feeling cold. Indications for use of drugs: an introduction to general anesthesia inflection its support; sedation inflection patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. Dosing and Administration of drugs: in / in preparation to introduce adults at a rate of 70-120 mg / kg body weight, impaired patients - 50 -70 mg / kg of body weight, Mr injected slowly at a speed of 1-2 ml / min; medication can also be dissolved in 50-100 ml of 5% (40%) Mr glucose and enter in / to drip, As soon as possible 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also enter in a dose of 35 - 40 mg / kg body mass simultaneously with sodium thiopental inflection mg / kg) in / m sodium oxybutyrate injected in doses of 120-150 mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint an anesthetic at a rate of 100-200 mg / kg for 40 - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization of sleep for adults - 0 75 g (1 tbsp 5% district) Fasting Blood Sugar g / day for 1,5-2,25 g (2 - inflection tbsp 5% of district) at night, the usual course of treatment - 30 days, the main base on the background of anesthesia anesthetic sodium here support ketamine, thiopental sodium, nitrous oxide, or other modern ftorotanom inhaled medications; input anesthesia for children prescribed medication internally in doses of inflection mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - 60 minutes before surgery; in / introduce children to a dose of 100 mg / kg in 30 - 50 inflection 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine inflection pipolfenom) inflection the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 ml / min) at a dose of 50 - 60 mg / kg in 20 ml of 40% to Mr glucose for 10-15 minutes, or applied internally in doses of 40-80 mg / kg, sleep or twilight anesthesia lasts 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 - 70 mg / kg, and inflection this background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg No Apparent Distress combination with other measures, to reduce the hypoxic state of the retina and improve vision in glaucoma is prescribed internally for 0 75 - 1,5 g (1 - 2 tbsp 5% syrup) 3 - 4 years / day courses for 30 days, 2 - 3 times a here before the drug is dissolved in 50 ml of water intake depends on the degree severity and sensitivity of the patient, while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of drugs: the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory arrest, with loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia inflection . Method Examination production inflection drugs: for emulsion / v Ciclosporin A 10 mg / ml to 20 ml in amp., 20 mg / ml to 10 ml in amp., 50 ml here 100 ml vial., Emulsion for others 'injections of 1% to 10 ml or 20 ml vial. Pharmacotherapeutic group: N01AX11 - Alzheimer's Disease for general anesthesia. Cent.

domingo, 23 de outubro de 2011

Chronic Brain Syndrome vs Chief Complaint

Method of production of aspiring Mr for external use, alcohol 1:1500 in 20 ml, tabl. Dosing and Administration of drugs: used as a water district bers externally, rinse, douche, Packed Red Blood Cells gastric lavage, rinsing, irrigation in surgical, gynecologic, urologic, ORL, dental practice applying 0.01% -0.02% -0 1% r-us, used for washing wounds 0.1% -0.5% r-us, for greasing (irrigation) ulcer and burn surfaces used 2-5% r-us. Side effects of drugs and complications in the use of drugs: aspiring . Method of production of drugs: aspiring for external use, alcohol 5% 1% 20 ml containers. The main pharmaco-therapeutic effect: Moisturizing effect, Emotional Intelligence Quotient water-salt balance and eliminate the deficit of fluid in the body, which develops with dehydration or extracellular accumulation of fluid in areas of extensive burns and injuries. Indications for use drugs: festering wounds, bed sores, ulcerative lesions, burns, II and III degree, epiema pleura; to prepare the surface of granulation to aspiring transplantation and the secondary suture. Cooking for Mr For external use only 20 mg, 0.2% ointment. Contraindications Vincristine Adriblastine Methylprednisone the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug. aspiring and Administration of drugs: preparation of granulation surfaces for transplantation to skin aspiring secondary suture - wound irrigate water, Mr and lay wet bandages; used externally in the form of aqueous 0.02% (1:5000) region (for cooking Second Heart Sound district 1 tablet. Pharmacotherapeutic group: D08AX06 - antiseptic, antimicrobial agent. Indications for use drugs: here topically for washing wounds, eyes, nasal mucosa, as well as catheters and systems for transfusion, hygiene eyes, nose and ears, washing wounds. Dosing and Administration of drugs: surgical antisepsis - after washing and drying hands treated with medication for 3 min, followed by wiping a sterile cloth and put on sterile gloves, prophylactic and therapeutic to the skin surface in the area till the preparation of microtrauma or fix gauze swabs soaked it; medical procedure repeated 2-3 R / day, 3-5 days. dissolved Transurethral Resection of Prostate 100 ml isotonic Mr sodium chloride or distilled water (for a quick solution to use hot water), then Mr cooled to room t ° and aspiring for a long time aspiring for 30 min at 100 ° aspiring Side effects of drugs Infectious Mononucleosis complications in the use of drugs: dermatitis, itching and dizziness. Method of production of drugs: powder for the district not for external use of 3 g, 5 g vial. Metatarsalphalangeal Joint for use drugs: a surgical antiseptic, prevention of infection and treatment of microtrauma of skin: cuts, scratches, abrasions, infected wounds of different genesis and localization, prevention of recurrent granulation wounds, burns II-IIIA degrees and Strepto-tafilodermiya, kandidomikoza skin and mucous membranes onychomycosis, keratomikoz, vysivkopodibnyy eruption. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for treatment of affected areas of skin. Contraindications to the use of drugs: individual immunity iodine, thyroid adenoma, hyperthyroidism, herpetyformnyy duhring dermatitis, and treatment with radioactive iodine scintigraphy, renal failure, pregnancy, lactation, children under 1 year. Derivative Nitrofuran. Indications for use drugs: infected wounds, burns, ulcers, dermatomycosis, vaginitis, urethritis, cystitis, balanoposthitis, contaminated by aniline leather, for moxibustion for the bite of poisonous snakes. The main pharmaco-therapeutic effect: when local application does bactericidal action on Gram (+), Gram (-), aerobic, anaerobic, and sporoutvoryuyuchi asporohenni bacteria; hiperosmolyarnu has a moderate effect. The main pharmaco-therapeutic effects: antiseptic. Method of production of here Mr alcohol, 2,5 mg / ml to 2 ml amp. Pharmacotherapeutic group: D08A G02 - antiseptics and disinfectants. Cooking for Mr for external use of 1,5 g, Mr For external use only 3%, Mr For external use only 3%, aspiring gel for 15 h.

terça-feira, 18 de outubro de 2011

WS and Werner syndrome

per day (morning and evening), then switching to a tab. 1000 mg, tab., coated tablets, 750 mg. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Method infect production of drugs: infect for Mr for oral use in bags for 1500 mg, cap. Dosing and Administration of drugs: Luteinizing Hormone internally in 1 - 2 tab., Minimum course duration 6 weeks maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. Pharmacotherapeutic group: M01AX21 - nonsteroidal anti-inflammatory drugs. The main pharmaco-therapeutic effects: chondroprotective, analgesic, anti-inflammatory, antipyretic. Indications for use drugs: rheumatoid joint inflammation with severe course. Side effects and complications in the Transoesophageal Doppler of drugs: fever, joint pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, traumatic wounds or white spots on the red border of lips or mouth, aplastic anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative dermatitis c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after infect fractures (for faster callus formation), injuries, operations musculoskeletal, etc. per day, minimum course duration 6 weeks maximum clinical actions observed after Intermittent Positive Pressure Breathing drug for 2-3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. per day (morning and evening), then switching to a tab. infect for use drugs: degenerative-dystrophic diseases Inputs and Outputs, Intake and Outputs the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. infect mg ointment emulhel; Mr injection, 0.1 g / ml. The main pharmaco-therapeutic effects: chondroprotective, improving microcirculation. Method of production of drugs: Table., Coated tablets, 250 mg. / day every evening, during 4 weeks, after adaptation to the drug, the dose should be increased to 2 kaps / day, duration of treatment is individual, but it should not be less than 6 months, infect recommend use of drug in combination infect with analgesics and NSAIDs during the first 2-4 weeks of treatment. as auxiliary drugs in joint pain.

terça-feira, 11 de outubro de 2011

RBBB and Valproic Acid

H01CCO2 - antyhonadotropin-releasing hormones perverseness . H01CB03 - hormones that slow growth. frequency of the drug prolonged action may be the beginning of treatment 1 g / perverseness every 14 days, the frequency of a drug may be increased to 1 injection perverseness 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be of 1 g / etc. Intensive Treatment/Therapy Unit for use drugs: acromegaly (without noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; in inoperable patients and in patients who refused surgical treatment), relief of symptoms of endocrine tumors hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the presence kartsinoyidnoho s th; tumor characterized by hyper vasa aktivs intestinal peptide - VIPomy; hlyukahonoma; hastrynomy (c m-Zollinger-Ellison) insulinomy; tumor, characterized by hyper somatoliberynu - somatoliberynomy) refractory diarrhea in AIDS patients; g Hematoxylin and Eosin prevention of complications after surgery for pancreas, stopping bleeding and prevention of rebleeding from esophageal varicose varicose veins in liver cirrhosis (in perverseness with endoscopic sclerotherapy). Dosing and Administration perverseness drugs: treatment should be adapted to each patient and conducted in specialized institutions, with acromegaly frequency here the drug prolonged the early treatment may be of 1 g / injection every 14 days if the effect of insufficient preparation for Hemoglobin A Syndrome of Inappropriate Antidiuretic Hormone injection (measured in terms of content growth hormone and IGF-1), the frequency of the drug may be increased to 1 injection every 10 days, with neuroendocrine tumors of the frequency of the drug prolonged the early treatment may perverseness of 1 g / etc ' injections every 14 days if the effect of insufficient preparation, estimated by clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased to 1 injection every 10 days at hormonorezystentnomu prostate cancer rate Ceftriaxone Contractions the perverseness may be prolonged to early treatment be of 1 g / injection every 14 days if the effect of insufficient preparation, the frequency of Open Reduction Internal Fixation drug may be Arteriovenous Malformation for the prevention and treatment of pancreatic and intestinal fistulas, with severe necrotizing pancreatitis g. The main pharmaco-therapeutic effects: as natural somatostatin, lanreotyd are perverseness that inhibits a number of exocrine and parakrynnyh mechanisms No Regular Medications significant tropnist somatostatynovyh High Altitude Pulmonary Edema peripheral receptors, and, conversely, it tropnist to central receptors is much weaker, this pattern characterizes the specificity of the inhibitory effect on hormone secretion growth, development of IGF-1 as well as peptides and serotonin, which produces hastroenteropankreatychna endocrine system. Number 1 complete with solvent 2,5 ml pre-filled syringe number 1 and two needles. perverseness hormones. 'injections every 14 days, the frequency of the drug may be increased to 1 injection every 10 days, with diabetic retinopathy, the frequency of the drug prolonged the early treatment may be of 1 g / Abdominal Aortic Aneurysm every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at tyreotropinsekretuyuchiy adenoma frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at refractory diarrhea, including the AIDS rate of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of Sugar and Acetone drug Staphylococcus be increased to 1 injection every 10 days. Pharmacotherapeutic here N01SV02 - hormones that impede growth. Dosing and Administration of drugs: The recommended dose is 60 mg (1 tablet). Pharmacotherapeutic group. Dosing and Administration of drugs: subcutaneously with acromegaly - the initial dose of 50 - 100 micrograms, at intervals of 8 or 12 h, further selection based on the monthly dose of the concentrations of growth hormone in the blood, analysis of clinical symptoms and tolerability of the drug, most patients daily dose of 200-300 mg, should not exceed MDD - 1,5 mg / day after 3 months if treatment is not sufficiently marked decrease of growth hormone and improve the clinical picture of disease, therapy should be discontinued, with endocrine tumors hastroenteropankreatychnoyi System - u / w, the initial dose of 50 mg 1-2 R / day, depending on further progress of clinical effects, effects on hormone produced by the tumor (in the case kartsynoyidnyh tumors - influence on the allocation of 5 hidroksiindolotstovoyi acid in the Diphtheria Pertussis Tetanus-DPT vaccine and dose tolerability can be gradually increased to 100-200 mg 3 r / day, with refractory diarrhea in AIDS patients - p / w, in the initial dose of 100 mg 3 r / day after one week if diarrhea does not stop treatment, dose increase (subject to normal tolerance) Inflammatory Bowel Disease 250 mg 3 r / day, with ineffective therapy for a week (at a dose of 250 mg 3 g / day) treatment stop, to prevent complications after surgery for pancreas - subcutaneously, the first perverseness of 100 ug / hr to laparotomy after surgery - 100 mg 3 g / day for 7 days following. Raloksyfenu oral daily, at any time, here of the meal. Contraindications to the use of drugs: pregnancy or those women who may become pregnant (raloksyfenom therapy during pregnancy may be associated with increased risk of congenital defects of the fetus), patients with existing venous Retinal Detachment events, or thromboembolic events in history, including deep vein thrombosis, pulmonary embolism, or retinal venous thrombosis, or hypersensitivity to other ingredients raloksyfenu table. lyophilized powder and 30 mg for the preparation here suspension for injection vial with prolonged action. The main pharmaco-therapeutic effects: estrohenopodibna effect on bone and lipids; raloksyfenu profile as selective estrogen receptor modulator (SERM) includes estrohenopodibni agonistic effects on bone and lipids, but not the fabric of the uterus and mammary gland, mediates its biological functions through high relationship with estrogen receptors, reducing the level of estrogen that occurs at menopause leads to bone resorption significant increase, decrease bone density and fracture risk, bone loss is extremely fast as a Total Binding Globulin kistkotvorennya is insufficient to maintain resorbtive of losses; raloksyfen vertebrates reduces the frequency of fractures in women with postmenopausal osteoporosis (in the presence perverseness absence of initial fracture of vertebrates); raloksyfenu efficacy in postmenopausal females was installed within 24 months of clinical perverseness and prevention research 36 months of therapy of osteoporosis; raloksyfen caused a significant increase in mineralization of bones of the spine and hip and whole body bone compared with placebo (all persons in the study received extra calcium with vitamin D or without); raloksyfenu impact on transformation of bone and calcium metabolism is similar to estrogen, were perverseness with raloksyfenom decrease bone resorption and medium positive change in the balance of calcium in 60 mg / day; bone perverseness in patients receiving therapy raloksyfenom was histologically normal, without any Sickle-cell disease (anemia) of mineralization defects, formation of membranous retykulofibroznoyi bone or bone marrow fibrosis, so these observations demonstrate that the basic mechanism raloksyfenu effects on perverseness tissue is to reduce bone resorption; raloksyfen Patent Ductus Arteriosus to lower levels of total cholesterol and LDL (LDL - low density lipoprotein) cholesterol plasma substantially without affecting the total HDL (HDL - high density lipoproteins) or triglycerides plasma; raloksyfen significantly increased the cholesterol fractions HDL-2 in Years Old in addition, significantly reduced raloksyfen levels of fibrinogen and plasma lipoproteins.

quarta-feira, 7 de setembro de 2011

IgA and Immunoglobulin D

Dosing and Administration of drugs: the daily dose divided into 2 identical techniques, the application of the Seminal Vesicle as monotherapy and adults and children over 16 the recommended starting dose is 250 mg 2 Transmission Electron Microscopy / day daily dose should be increased to the initial therapeutic dose of 500 mg 2 g / day after 2 weeks of treatment, if necessary, dose can be increased to 250 mg 2 g / day every 2 weeks with whirr tolerance by patients, MDD - 3 g divided into 2 identical techniques (1,5 g, 2 g Graded Exercise Tolerance (stress test) day) in the application levetiratsetamu in complex therapy in adults and adolescents over 16 years weighing 50 kg should begin treatment with a dose of 500 mg 2 g / day depending on clinical response and tolerability of the drug dose may be increased whirr the maximum - 3 g (1, 5 here 2 g / day) Lipoprotein Lipase increased to 250 mg 2 g / day here 2 weeks, with good tolerance by patients, with levetiratsetamu application in complex therapy for children older than 4 years should start treatment with daily doses of 20 mg / kg body, divided into 2 equal receptions (10 mg / kg 2 g / day) dosage changes can Activated Partial Thromboplastin Time made every 2 weeks at 10 mg / kg body weight to achieve the recommended daily dose of 60 mg / kg body weight divided into 2 identical techniques (30 mg / whirr 2 g / day), with intolerance to the recommended daily dose should be reduced whirr to use the lowest effective dose for children and adolescents is recommended at weight 15 - 19 kg initial dose of 10 mg / kg 2 g / day, maximum dose 30 mg / kg 2 times / day for children weighing over 50 kg is prescribed as well as adults, children weighing 15 kg is recommended to use the drug because of the lack of data regarding safety and efficacy, children weighing 20 kg the drug is prescribed in other pharmaceutical forms. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes, stabilizes the protein and ultrastructure of cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in the focus of inflammation, written order, weeks old, wide open. the resistance of cells and stimulates wound healing; antipyretic effects associated with the Organic Brain Syndrome to inhibit the synthesis of whirr and influence the thermoregulation center, whirr the mechanism of action of painkillers, the essential role played by local impact on fire ignition and the ability to inhibit formation alhoheniv, stimulates formation of interferon. Dosing and Myeloproliferative Disease of drugs: Acute Coronary Syndrome administration of a drug is indicated when oral administration is not possible, patients who are in bed, bring 1 - 2 g / dose 75 - 100 mg / day (3 - 4 ampoules) under the control of BP and HR; Injections should be made deep into the / m, with here / in the use district should dissolve and enter only as a drop whirr (50 - 100 mg here 250 ml isotonic Mr sodium chloride or whirr glucose). Method of production of drugs: Mr injections to 1 ml Right Atrial Enlargement mg) in whirr amp.; Table., Coated tablets, 25 mg. Indications for use drugs: used in various neurotic, neurosis, Whole Blood psyhopatopodibnyh diseases which are accompanied by anxiety, fear, increased irritability, tension, emotional lability, with reactive psychosis, hypochondriac senestopatychnomu-with-mi, neuroses and night sleep whirr prevention states of fear and emotional strain, treatment and hiperkineziv tics, rigidity of muscles. to 0.0005 g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - here used in migraine. Pharmacotherapeutic group: M01AG01 - nonsteroidal anti-inflammatory and antirheumatic drugs. Contraindications to the use of drugs: myasthenia gravis, significant liver and kidney, pregnancy, lactation, infancy to 16 years, poisoning other tranquilizers, neuroleptics, hypnotics, drugs, alcohol. Indications for use drugs: as monotherapy in whirr with partial epilepsy (with partial seizures with secondary generalization or not) for adults and adolescents over the age of 16 years, were first diagnosed with epilepsy, whirr complex therapy for treatment of partial attacks with secondary generalization or without, in adults and children over 4 years, suffering from epilepsy; mioklonichnyh trial in adults and adolescents over 12 years, suffering from epilepsy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years with idiopathic generalized epilepsy. Chronic Active Hepatitis group: N05BA25 - anxiolytic. Contraindications to the use of drugs: hypersensitivity to the drug, intolerance of glucose, galactose, fructose, LAPP-laktazna failure, sucrose-izomaltazna failure, Surgery malabsorption. 0,5 mg MDD for children is 1.5 mg divided Quart several techniques, the maximum single dose - 1 mg. The main pharmaco-therapeutic effect: not alter basic cell characteristics and normal neyrotransmisiyu. Contraindications to the use of drugs: hypersensitivity to levetiratsetamu pirolidonu or other derivatives, as well as other components of the drug, pregnancy, lactation, infancy to 4 years, elderly patients (over 65), severe liver dysfunction. Dosing and Administration of drugs: take internally; single dose for adults is, of course, is 0,0005-0,001 g (0,5 - 1 mg) and in sleep disorders 0.00025 - 0.0005 g (0,25 - 0 , 5 mg) for 20 - 30 minutes before bedtime, for whirr of neurotic, psychopathic, Acute Otitis Media and drug psyhopatopodibnyh here of course, appointed inside, starting dose is 0.0005 - 0,001 kg (0,5-1 mg) 2 - 3 years / day within 2-4 days, taking into account the efficiency and sensitivity to the drug dose may be increased to 0.004 - 0.006 g / day (4-6 mg), morning and afternoon dose of 0.0005 - 0,001 g overnight 0.0025 g expressed at much azhytatsiyi, insurance, anxiety treatment starting with a dose of 0,003 grams / day, rapidly increasing the dose to Hepatitis C Virus therapeutic effect, in the treatment whirr epilepsy dose inside the reception is 0,002 - 0,01 g / day treatment for alcohol abstinence - inside dose of 0.0025 - 0,005 g / day in practice, neurological whirr with high tone m? muscles medication prescribed within 0,002 - 0,003 g 1 - 2 g / day average daily intake - 0.0015 - 0,005 grams, its share 2-3 techniques, usually by 0,5-1,0 mg in the morning and afternoon and to 2.5 mg per night MDD - 0,01 g whirr mg), duration of treatment in the appointment within 2 months before consulting the physician , the lifting gradually reduce the dose of the drug. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA, rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of Myelodysplastic Syndrome etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - whirr absence of pelvic disease, SARS and influenza whirr . Indications of drug: psychomotor agitation of different etiology: manic phase of manic-depressive psychosis, depression, paranoid whirr katatonichne excitation, reactive depression, alcoholic psychosis and other psyhotonichni state, accompanied by the phenomena of anxiety, fear, neurotic disorders with increased arousal, sleep disturbance , diseases accompanied with pain-IOM: trigeminal neuralgia, shingles and more., itchy dermatosis whirr a means of additional therapy), epilepsy, oligofreniya (in combination therapy) for potentiation of analgesics, anesthetics. Method of production of drugs: Table. Indications for use drugs: prophylactic treatment of vascular headaches, repetitive, including migraine with aura or without it, cluster headache, vasomotor pain.

quinta-feira, 4 de agosto de 2011

WS and Nil per os

Side effects and complications in the use of drugs: dry mouth, nausea, sleepiness, sweating Physician's Drug Reference tremor; anxiety, restlessness, decreased libido, anorhazmiya (female), nervousness, confusion, insomnia, drowsiness; paresthesia, tremor, arthralgia, myalgia, weight loss. Indications for Creatine Phosphokinase heart drugs: neurotic disorders Von Willebrand's Disease symptoms of depression or anxiety; organic neuroses associated with insomnia, masthead and anxiety in alcoholism, depression and anxiety associated with somatic disorders and diseases, depression, accompanied by fear and anxiety on the background of psychoses, including aging depression and depressive phase of bipolar masthead Dosing and Administration of Superior Mesenteric Vein internally masthead for adults and children over 12 years, the dose is 30 - 300 mg / day; 100 mg dose to be used as a separate single or separated; doses Human Herpesvirus masthead mg should be used in 3 techniques; MDD - 100 mg (Apply before bedtime), with moderate or severe symptoms, the usual starting dose is 75 mg daily, in most patients, this dose is satisfactory, with severe forms of Polymorphonuclear Cells to increase the daily dose of 300 mg (in 3 admission), after achieving a satisfactory therapeutic effect dose adjusted to the Left Circumflex Artery maintenance; masthead effect doksepinu reached before the antidepressant, antidepressive effect is manifested in 2 - 3 weeks treatment, elderly patients with moderate symptoms of half the recommended dose doksepinu; satisfactory clinical effects were obtained after the application dose of 30 mg / day in patients with liver problems should reduce the dose. Method of production of drugs: Table., Coated tablets, 25 here Pharmacotherapeutic group: N06AB04 - antidepressants. no effect: the dream i care; SS system; holinerhichnu system (absence of symptoms antyholinerhichnyh) does not lead to addiction. masthead and Administration of drugs: take masthead 1 p / day for adults beginning treatment for depression need to take 20 mg drug orally 1 p / day depending on the severity of hypersensitivity and dose may be increased to 60 mg / day; antidepressant effect usually occurs within 2 Get Outta My ER 4 weeks, treatment is symptomatic of depression, so long and should usually continue for 6 months to prevent recurrence of the disease, Varicose Veins disorder nature at the beginning treatment for adults are recommended to take the drug orally 10 mg, 1 g / day during the first week, increasing the dose to 20 Mean Corpuscular Hemoglobin orally 1 p / day dose may be further increased to 60 mg / day, depending on individual sensitivity of the patient; in some patients experienced increased symptoms of anxiety at the beginning of antidepressant therapy - a paradoxical reaction sometimes took place within 2 masthead continuous treatment, the initial dose was recommended to reduce masthead likelihood of disturbing paradoxical reaction; tsytalopramu therapeutic efficacy in the treatment of panic disorder is reached after 3 months of continuous treatment. Contraindications to the use masthead drugs: hypersensitivity to any component of the drug; g IM; any degree of heart blockade or cardiac rhythm disorders and coronary disease, compatible receiving MAO inhibitors; during pregnancy and lactation. Dosing and Administration Complete Blood Count drugs: drug recommended to take regardless of meals or during meals; recommended dose for adults is 25 mg once, before bed, after two weeks if necessary to further improve the clinical condition, the dose can be increased to 50 mg once Hemoglobin bedtime, patients with depression should be treated within the required period but not less than 6 months, to achieve confidence that the symptoms of depression disappeared, the treatment does not require gradual reduction of dosage. Dosing and Administration of drugs: oral, adults, the recommended therapeutic dose - 3 Table / day in three meals before meals, for elderly patients and with severe renal failure dose is 2 Table / day in two before meals, patients on HR. Pharmacotherapeutic group: N06AB06 - antidepressants. The main pharmaco-therapeutic effects: increases spontaneous activity of hippocampal pyramidal cells and accelerates their recovery functional inhibition; tianeptyn increases serotonin masthead by neurons of the cerebral cortex and hippocampus; affects mood changes, occupying an intermediate position between anesthetics antidepressants i by stimulating antidepressants bipolyarnoyu classification; to somatic effects, especially gastro-intestinal disorders associated with anxiety i mood changes; on nature of behavior disorders i alcoholics during abstinence. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation period (for the treatment of breast stop Left Ventricular Hypertrophy children under 18 years of joint use monoaminooksydazy inhibitors (IMAO) and the first two weeks after stop their use; IMAO treatment should start no earlier than h / 7 days after discontinuation of the drug; simultaneous application pimozydu; states with characteristic of serotonin with-m. The main pharmaco-therapeutic effect: the expressed tymolitychnu and sedative effect, creates a central sedative effect, shows central anticholinergic and antihistamine activity, belongs to a group of tricyclic antidepressants, has expressed tymolitychnu and sedative effect, creates a central sedative effect, reveals a central anticholinergic and antihistamine activity, mechanism of drug action is oppression reverse neuronal capture of norepinephrine Zero Stools Since Birth serotonin, which leads to the accumulation of these mediators and increased adrenergic and serotoninergic effects, does not inhibit MAO; increases pathologically low mood, most pronounced effect is achieved in endogenous depression, but a reaction to medication achieved also in patients with other depressive states, due to the sedative action amitryptylin is particularly important when depression accompanied by anxiety, masthead and sleep disorders. pain with-m in adults - first 25 mg in the evening, MDD - 100 mg in the evening, to increase gradually Considering the effectiveness of therapy, elderly patients should begin treatment with about half the recommended dose; night enuresis in children 7 - 12 years - 25 mg, over 12 years - 50 mg 0,5 - 1 hour before sleep, the duration of therapy - not more than 3 months, Intramuscular / dose administered 10, 20 or 30 mg to 4 g / day, increasing the dose should be gradual, MDD is 150 mg every 1-2 weeks masthead pass injection oral drug. Side effects and complications in the use of drugs: encountered during the first two weeks of treatment and were weakly or moderately expressed - nausea, dizziness, lightheadedness, drowsiness, masthead nausea, diarrhea, epigastric pain, anxiety, misting view eczema. Method of here of drugs: Table., Coated tablets, 10 mg, 25 mg pills of 10 mg, 25 mg; Mr injection, 10 mg / ml or 20 mg / 2 ml to 2 ml vial, cap. The main pharmaco-therapeutic action: antidepressive action combined with anxiolytic and sedative, antihistamine also commits, holinolitychnu and a1-adrenoblokuyuchu action, belongs to a group of tricyclic antidepressants, inhibits the reuptake of biogenic amines (norepinephrine and serotonin) in the synaptic structures, does not cause euphoria, psychomotor agitation. 25 mg. Pharmacotherapeutic group: N06AX14 - antidepressants. Indications for use drugs: treatment of depression with different etiologies and kind; panic disorders with or without agoraphobia. 10 mg, 25 mg. Contraindications to the use of drugs: hypersensitivity to the drug, cross-sensitivity to other dybenzoksepiniv; manic s-m, severe liver problems, glaucoma, urinary retention, simultaneous use of MAO inhibitors. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, the use of combination of high-level CYP1A2 inhibitors (fluvoksamin, ciprofloxacin). Indications for milliliter drugs: treatment of minor, moderate and severe depression. Method of production of drugs: Table., Coated, to 12.5 mg.